Douglas S. Richardson

Success of transdisciplinary science requires monodisciplinary support

Douglas S. Richardson, 2016, Cell Biology and Toxicology.

Transcript level modulates the inherent oncogenicity of RET/PTC oncoproteins.

Douglas S. Richardson, L. Mulligan, S. Asa, 2009, Cancer research.

Intracellular distribution of TM4SF1 and internalization of TM4SF1-antibody complex in vascular endothelial cells.

Douglas S. Richardson, H. Dvorak, Tracey E. Sciuto, 2015, Biochemical and biophysical research communications.

Alternative splicing results in RET isoforms with distinct trafficking properties

Douglas S. Richardson, L. Mulligan, Brandy D. Hyndman, 2012, Molecular biology of the cell.

RET‐mediated gene expression pattern is affected by isoform but not oncogenic mutation

Douglas S. Richardson, J. Brettschneider, L. Mulligan, 2009, Genes, chromosomes & cancer.

RET ligand-induced internalization and its consequences for downstream signaling

Douglas S. Richardson, L. Mulligan, D. Richardson, 2006, Oncogene.

RET-mediated cell adhesion and migration require multiple integrin subunits.

Douglas S. Richardson, L. Mulligan, Taranjit S. Gujral, 2010, The Journal of clinical endocrinology and metabolism.

A novel RET kinase-beta-catenin signaling pathway contributes to tumorigenesis in thyroid carcinoma.

Douglas S. Richardson, L. Mulligan, B. Elliott, 2008, Cancer research.

Loss of Tumour Suppressor TMEM127 Drives RET-mediated Transformation Through Disrupted Membrane Dynamics

Douglas S. Richardson, L. Mulligan, Michael G. Sugiyama, 2023, bioRxiv.